Cuspidi Cesare, Faggiano Andrea, Gherbesi Elisa, Sala Carla, Grassi Guido, Tadic Marijana
Department of Medicine and Surgery, University of Milano-Bicocca, 20126 Milano, Italy.
Department of Clinical Sciences and Community Health, University of Milano, 20122 Milano, Italy.
Rev Cardiovasc Med. 2023 Feb 22;24(3):64. doi: 10.31083/j.rcm2403064. eCollection 2023 Mar.
The hypertensive response to exercise testing, defined as exaggerated blood pressure response (EBPR), has been documented to be independently associated with unhealthy conditions, carrying an increased risk of future hypertension, cardiovascular (CV) morbidity and mortality. In treated hypertensives, EBPR is a marker of uncontrolled hypertension, a condition previously undetected by office blood pressure (BP) measurements at rest; EBPR may also detect masked hypertension, a phenotype characterized by normal BP values in the medical environment but elevated home or ambulatory BP monitoring (ABPM). The aim of the present review is to provide a comprehensive and up-dated information on the clinical importance of EBPR targeting the following issues: (I) definition and prevalence; (II) underlying mechanisms; (III) clinical correlates and association with subclinical organ damage; (IV) predictive value; (V) clinical decision making.
运动试验中的高血压反应,定义为血压过度反应(EBPR),已被证明与不健康状况独立相关,会增加未来患高血压、心血管(CV)疾病和死亡的风险。在接受治疗的高血压患者中,EBPR是未控制高血压的一个标志,这是一种之前在静息状态下通过诊室血压(BP)测量未被发现的情况;EBPR还可能检测到隐匿性高血压,这是一种在医疗环境中血压值正常但家庭或动态血压监测(ABPM)显示血压升高的表型。本综述的目的是提供关于EBPR临床重要性的全面且最新的信息,针对以下问题:(I)定义和患病率;(II)潜在机制;(III)临床相关性以及与亚临床器官损害的关联;(IV)预测价值;(V)临床决策。